Quantcast
Home > Quotes > EVFM
EVFM

Evofem Biosciences, Inc. Common Stock (EVFM) Quote & Summary Data

$6.25
*  
0.15
2.34%
Get EVFM Alerts
*Delayed - data as of Apr. 20, 2018  -  Find a broker to begin trading EVFM now
Exchange:NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Key Stock Data

Best Bid / Ask
N/A / N/A
1 Year Target
15
Today's High / Low
$ 6.26 / $ 5.6955
Share Volume
9,617
50 Day Avg. Daily Volume
10,187
Previous Close
$ 6.40
52 Week High / Low
$ 15.7801 / $ 1.80
Market Cap
111,020,875
Annualized Dividend
N/A
Ex Dividend Date
N/A
Dividend Payment Date
N/A
Current Yield
0 %
Beta
-0.48

Special Dividend Data

Special Dividend
N/A
Special Dividend Date
Jan. 18, 2018
Special Dividend Payment Date
N/A

Intraday Chart

Shares Traded

Share Volume:
9,617
50 Day Avg. Daily Volume:
10,187

P/E Ratio

P/E Ratio:
NE
Forward P/E (1y):
Earnings Per Share (EPS):
$ -4.14

Trading Range

The current last sale of $6.25 is 247.22% Higher than the 52 week low.

Intraday Last 52 Weeks
High: $ 6.26 $ 15.7801
 Low: $ 5.6955 $ 1.80

Company Description (as filed with the SEC)

On January 17, 2018, Neothetics, Inc., or Neothetics, and privately-held Evofem Biosciences Operations, Inc., or Private Evofem, completed the merger and reorganization, or the Merger, in accordance with the terms of the Agreement and Plan of Merger and Reorganization, dated October 17, 2017, or the Merger Agreement, by and among Neothetics, Private Evofem and Nobelli Merger Sub, Inc., a wholly owned subsidiary of Neothetics, or Merger Sub, whereby Merger Sub merged with and into Private Evofem, with Private Evofem surviving as a wholly owned subsidiary of Neothetics. The Merger was structured as a reverse capitalization and Private Evofem was determined to be the accounting acquirer based on the terms of the Merger and other factors.  ... More ...  

Risk Grade

Where does EVFM fit in the risk graph?


Risk Grade Scale

Nasdaq Official Price

Open Price:
$ 6.23
Open Date:
Apr. 20, 2018
Close Price:
$ 6.20
Close Date:
Apr. 20, 2018

Consensus Recommendation

Analyst Info